FIELD: biochemistry, pharmacy. SUBSTANCE: invention proposes pharmaceutical composition involving inhibitor of aldehyde reductase and inhibitor of ACE taken in the definite ratio and used for treatment of diabetic neuropathy. The novel agent enhances significantly the rate of nervous conductivity due to synergetic effect of components. EFFECT: expanded arsenal of agents of indicated designation, valuable medicinal and biochemical properties. 5 cl
Authors
Dates
2003-11-20—Published
1998-07-02—Filed